No images? Click here ![]() Monday, 17 March 2025 MEDIA ADVISORY Virtual press conference on the outcomes of the Strategic Advisory Group of Experts on Immunization (SAGE) meeting The Stategic Advisory Group of Experts on Immunization (SAGE) held their regular biannual meeting from 10 to 13 March, to discuss recommendations on the use of a range of vaccines including pneumococcal, varicella and herpes zoster, and polio, and country prioritization efforts on new vaccine introductions, among other topics. Major recommendations will be announced and discussed during this virtual press conference When: Tuesday, 18 March 2025 at 16.00 CET (Geneva time)
Speakers:
Join by Zoom:
https://who.zoom.us/j/99290105894 Password: WHO&18SAGE Telephone: Dial (for higher quality, dial a number based on your current location): US: +1 651 372 8299 or +1 669 219 2599 or +1 669 900 9128 or +1 720 928 9299 or +1 786 635 1003 or +1 971 247 1195 or +1 213 338 8477 or +1 253 215 8782 or +1 267 831 0333 or +1 301 715 8592 or +1 312 626 6799 or +1 346 248 7799 or +1 470 250 9358 or +1 470 381 2552 or +1 602 753 0140 or +1 646 518 9805 or +1 646 558 8656 Webinar ID: 992 9010 5894 Password: 9056439517 International numbers available: https://who.zoom.us/u/ab8mPvxlZ3 Join by SIP Notes to journalists: Please ensure you enter your name and media outlet (use name/outlet). Kindly note that only questions from the media are allowed. When you sign in, you will be automatically put in the meeting room. Make sure you have a microphone connected or active on your computer. Click "raise hand" to ask a question (find the icon under the tab participants); this will enter you into the queue for questions. We cannot guarantee that questions asked in the chat will be incorporated into the Q&A session.WHO reserves the right to remove any participant whose behaviour causes any disruption. The event will also be broadcast on WHO social media channels, and you can follow it there. ![]() Media contacts: You are receiving this NO-REPLY email because you are included on a WHO mail list. |
0 Comments